These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22721802)

  • 1. An aminoquinazoline inhibitor of the essential bacterial cell wall synthetic enzyme GlmU has a unique non-protein-kinase-like binding mode.
    Larsen NA; Nash TJ; Morningstar M; Shapiro AB; Joubran C; Blackett CJ; Patten AD; Boriack-Sjodin PA; Doig P
    Biochem J; 2012 Sep; 446(3):405-13. PubMed ID: 22721802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition studies on Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase (GlmU).
    Tran AT; Wen D; West NP; Baker EN; Britton WJ; Payne RJ
    Org Biomol Chem; 2013 Dec; 11(46):8113-26. PubMed ID: 24158720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PknB-mediated phosphorylation of a novel substrate, N-acetylglucosamine-1-phosphate uridyltransferase, modulates its acetyltransferase activity.
    Parikh A; Verma SK; Khan S; Prakash B; Nandicoori VK
    J Mol Biol; 2009 Feb; 386(2):451-64. PubMed ID: 19121323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of substrate binding and catalysis in the potential antibacterial target N-acetylglucosamine-1-phosphate uridyltransferase (GlmU).
    Mochalkin I; Lightle S; Zhu Y; Ohren JF; Spessard C; Chirgadze NY; Banotai C; Melnick M; McDowell L
    Protein Sci; 2007 Dec; 16(12):2657-66. PubMed ID: 18029420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of novel small molecule inhibitors of the acetyltransferase activity of Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU).
    Sharma R; Rani C; Mehra R; Nargotra A; Chib R; Rajput VS; Kumar S; Singh S; Sharma PR; Khan IA
    Appl Microbiol Biotechnol; 2016 Apr; 100(7):3071-85. PubMed ID: 26563552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design of inhibitors of the bacterial cell wall synthetic enzyme GlmU using virtual screening and lead-hopping.
    Doig P; Boriack-Sjodin PA; Dumas J; Hu J; Itoh K; Johnson K; Kazmirski S; Kinoshita T; Kuroda S; Sato TO; Sugimoto K; Tohyama K; Aoi H; Wakamatsu K; Wang H
    Bioorg Med Chem; 2014 Nov; 22(21):6256-69. PubMed ID: 25262942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structures of Streptococcus pneumoniae N-acetylglucosamine-1-phosphate uridyltransferase, GlmU, in apo form at 2.33 A resolution and in complex with UDP-N-acetylglucosamine and Mg(2+) at 1.96 A resolution.
    Kostrewa D; D'Arcy A; Takacs B; Kamber M
    J Mol Biol; 2001 Jan; 305(2):279-89. PubMed ID: 11124906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of a small-molecule inhibitor complexed with GlmU from Haemophilus influenzae reveals an allosteric binding site.
    Mochalkin I; Lightle S; Narasimhan L; Bornemeier D; Melnick M; Vanderroest S; McDowell L
    Protein Sci; 2008 Mar; 17(3):577-82. PubMed ID: 18218712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and function of GlmU from Mycobacterium tuberculosis.
    Zhang Z; Bulloch EM; Bunker RD; Baker EN; Squire CJ
    Acta Crystallogr D Biol Crystallogr; 2009 Mar; 65(Pt 3):275-83. PubMed ID: 19237750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro validation of acetyltransferase activity of GlmU as an antibacterial target in Haemophilus influenzae.
    Buurman ET; Andrews B; Gao N; Hu J; Keating TA; Lahiri S; Otterbein LR; Patten AD; Stokes SS; Shapiro AB
    J Biol Chem; 2011 Nov; 286(47):40734-42. PubMed ID: 21984832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of the acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridylyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 2: Optimization of physical properties leading to antibacterial aryl sulfonamides.
    Stokes SS; Albert R; Buurman ET; Andrews B; Shapiro AB; Green OM; McKenzie AR; Otterbein LR
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7019-23. PubMed ID: 23099094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design of diverse inhibitors of Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase: combined molecular docking, dynamic simulation, and biological activity.
    Soni V; Suryadevara P; Sriram D; ; Kumar S; Nandicoori VK; Yogeeswari P
    J Mol Model; 2015 Jul; 21(7):174. PubMed ID: 26078037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 1: Hit to lead evaluation of a novel arylsulfonamide series.
    Green OM; McKenzie AR; Shapiro AB; Otterbein L; Ni H; Patten A; Stokes S; Albert R; Kawatkar S; Breed J
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1510-9. PubMed ID: 22297115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computationally Guided Identification of Novel Mycobacterium tuberculosis GlmU Inhibitory Leads, Their Optimization, and in Vitro Validation.
    Mehra R; Rani C; Mahajan P; Vishwakarma RA; Khan IA; Nargotra A
    ACS Comb Sci; 2016 Feb; 18(2):100-16. PubMed ID: 26812086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
    Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
    Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures identify an atypical two-metal-ion mechanism for uridyltransfer in GlmU: its significance to sugar nucleotidyl transferases.
    Jagtap PK; Verma SK; Vithani N; Bais VS; Prakash B
    J Mol Biol; 2013 May; 425(10):1745-59. PubMed ID: 23485416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate-bound crystal structures reveal features unique to Mycobacterium tuberculosis N-acetyl-glucosamine 1-phosphate uridyltransferase and a catalytic mechanism for acetyl transfer.
    Jagtap PK; Soni V; Vithani N; Jhingan GD; Bais VS; Nandicoori VK; Prakash B
    J Biol Chem; 2012 Nov; 287(47):39524-37. PubMed ID: 22969087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of novel cell wall inhibitors of Mycobacterium tuberculosis GlmM and GlmU.
    Li Y; Zhou Y; Ma Y; Li X
    Carbohydr Res; 2011 Sep; 346(13):1714-20. PubMed ID: 21704310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GlmU (N-acetylglucosamine-1-phosphate uridyltransferase) bound to three magnesium ions and ATP at the active site.
    Vithani N; Bais V; Prakash B
    Acta Crystallogr F Struct Biol Commun; 2014 Jun; 70(Pt 6):703-8. PubMed ID: 24915076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the bifunctional N-acetylglucosamine 1-phosphate uridyltransferase from Escherichia coli: a paradigm for the related pyrophosphorylase superfamily.
    Brown K; Pompeo F; Dixon S; Mengin-Lecreulx D; Cambillau C; Bourne Y
    EMBO J; 1999 Aug; 18(15):4096-107. PubMed ID: 10428949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.